» Articles » PMID: 9322987

Time-dependent Effects of Low-dose Aspirin Administration on Blood Pressure in Pregnant Women

Overview
Journal Hypertension
Date 1997 Oct 10
PMID 9322987
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

This study investigated the effects of low-dose acetylsalicylic acid (aspirin) on blood pressure in pregnant women who were at risk of developing gestational hypertension or preeclampsia and who received aspirin at different times of the day according to their rest-activity cycle. A double-blind, randomized, controlled trial was conducted in 100 pregnant women. Blood pressure for each subject was automatically monitored for 2 days every 4 weeks from the day of recruitment until delivery. Women were randomly assigned to one of six groups according to treatment (placebo, 50 subjects or aspirin, 100 mg/d, starting at 12 to 16 weeks of gestation) and the time of treatment: on awakening (time 1), 8 hours after awakening (time 2), or before bedtime (time 3). Results indicated that there was (1) no effect on blood pressure from placebo at any time (P>.212) and (2) a highly statistically significant (P<.001) time-dependent effect on blood pressure from aspirin. There was no effect of aspirin on blood pressure at time 1 (compared with placebo), but the blood pressure reduction was highly statistically significant after time 2 and, to a greater extent, after time 3 (mean reduction of 12 and 8 mm Hg in 24 hours for systolic and diastolic blood pressure, respectively, at the time of delivery compared with placebo given at the same time). These time-dependent effects of aspirin on blood pressure should be taken into account for the optimization of long-term aspirin administration at low doses for prevention of preeclampsia. In any meta-analysis of aspirin effects, inquiries about the time when the subjects took the drug are indicated and may account for discrepancies in the literature.

Citing Articles

Redefining the Roles of Aspirin across the Spectrum of Cardiovascular Disease Prevention.

Brown M, Bortfeld K, Sperling L, Wenger N Curr Cardiol Rev. 2023; 19(6):9-22.

PMID: 37132104 PMC: 10636801. DOI: 10.2174/1573403X19666230502163828.


Aspirin for the prevention of preeclampsia: A systematic review and meta-analysis of randomized controlled studies.

Wang Y, Guo X, Obore N, Ding H, Wu C, Yu H Front Cardiovasc Med. 2022; 9:936560.

PMID: 36440041 PMC: 9682183. DOI: 10.3389/fcvm.2022.936560.


Association between aspirin use during pregnancy and cardiovascular risk factors 2-7 years after delivery: The nuMoM2b Heart Health Study.

Theilen L, Greenland P, Varagic J, Catov J, Shanks A, Thorsten V Pregnancy Hypertens. 2022; 28:28-34.

PMID: 35158155 PMC: 9133043. DOI: 10.1016/j.preghy.2022.01.012.


The role of aspirin dose and initiation time in the prevention of preeclampsia and corresponding complications: a meta-analysis of RCTs.

Yip K, Luo Z, Huang X, Lee W, Li L, Dai C Arch Gynecol Obstet. 2022; 305(6):1465-1479.

PMID: 34999942 DOI: 10.1007/s00404-021-06349-4.


Circadian Blood Pressure Rhythm in Cardiovascular and Renal Health and Disease.

Zhang J, Sun R, Jiang T, Yang G, Chen L Biomolecules. 2021; 11(6).

PMID: 34207942 PMC: 8230716. DOI: 10.3390/biom11060868.